The U.S. Department of Justice (DOJ) will investigate potential antitrust violations in the UnitedHealth Group (NYSE: UNH) subsidiary Optum’s forthcoming acquisition of Amedisys, Inc. (NASDAQ: AMED).
To date, neither Amedisys nor Optum have been accused of any wrongdoing. The DOJ performed a similar investigation when Optum acquired the health care technology company Change Healthcare earlier this year. A federal court eventually allowed that deal to proceed.
Subsequently, Optum closed a deal for the home health and hospice provider LHC Group for $5.4 billion.
Access the full article on Hospice News: Justice Department’s Amedisys-Optum Inquiry Reflects Growing Antitrust Concerns
About Hospice News
Hospice News (HN) is an independent source for breaking news and up-to-date information on the hospice industry. The coverage spans the hospice world specifically, from large, national service providers to independent care companies. Its news and perspective gives industry professionals the information they need to make the best decisions in their day-to-day business operations.
HN is owned and operated by Chicago-based Aging Media Network. For more information, visit https://hospicenews.com/. External Link. Opens in new window.. External Link. Opens in new window.. External Link. Opens in new window.. External Link. Opens in new window.. External Link. Opens in new window..